Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Telavive
Ari Raphael
29 tahun pengalaman
akreditasi :
Klinik telah bersertifikat :
Biaya perawatan NanoKnife di Israel biasanya berkisar dari $18,500 hingga $31,500. Harga bervariasi tergantung pada lokasi tumor, jumlah lesi yang diobati, pilihan rumah sakit, dan pengalaman ahli radiologi intervensional. Di Amerika Serikat, harga rata-rata adalah $40,000 (menurut NCCN). Ini berarti prosedur NanoKnife di Israel sekitar 38% lebih murah daripada di AS.
Di Israel, harga biasanya mencakup pencitraan pra-operasi, ablasi NanoKnife, anestesi, masa inap di rumah sakit (1–2 malam), dan tindak lanjut rutin. Di AS, Anda mungkin harus membayar lebih untuk pencitraan, anestesi, biaya rumah sakit, dan perawatan pasca-operasi. Selalu pastikan layanan dan perawatan setelahnya yang disertakan di setiap klinik.
Mengapa mempertimbangkan Israel untuk pengobatan nanoknife?
Akses solusi NanoKnife canggih di klinik terpercaya [dari-biaya].
| Israel | Turki | Austria | |
| NanoKnife | dari $18,500 | dari $9,500 | dari $25,000 |
Apa yang disukai pasien:
Apa yang tidak disukai pasien:
Sebagai platform pariwisata medis global terkemuka, kami memiliki tanggung jawab besar kepada pasien dan pusat medis di Israel. Semua informasi yang disediakan di Bookimed.com didasarkan pada penelitian, prediksi, dan keahlian serta memenuhi minat tinggi terkait produk NanoKnife dan mengikuti:
Kami membentuk daftar klinik dan dokter NanoKnife dengan regulasi ketat dari sistem peringkat otomatis cerdas kami. Sistem ini didasarkan pada penilaian pasien Bookimed yang nyata untuk memberikan informasi yang paling objektif dan transparan tentang klinik dan layanan medis NanoKnife di sana.
Data scientist berpengalaman kami mengumpulkan data setiap hari, memantau, dan mengoptimalkan sistem peringkat menggunakan pembelajaran mesin dan kecerdasan buatan untuk memastikan bahwa sistem peringkat selalu terbaru dan memberikan hasil yang akurat.
Kami mengumpulkan pendapat klien Bookimed hanya setelah mendapatkan pengalaman medis NanoKnife dengan klinik tersebut — sehingga semua orang di platform dapat mempercayai fasilitas yang mereka pilih. Kami berusaha untuk membuat konten di platform kami seberguna mungkin dan memastikan kebebasan untuk mengekspresikan pendapat kritis. Dengan demikian, kami mempublikasikan ulasan positif dan negatif, bertujuan menjadi sumber untuk pengambilan keputusan yang terinformasi bagi klien kami di masa depan.
Di Bookimed.com, Anda dapat menemukan pilihan dan kenyamanan untuk menemukan solusi medis NanoKnife terbaik dari penyedia layanan medis teratas di Israel hanya di satu tempat dan seringkali dengan harga yang kompetitif. Memastikan untuk memberikan informasi terbaru, perwakilan klinik memperbarui CV dokter, kapasitas klinik, gambar sebelum-sesudah, harga, paket, dan penawaran spesial dengan segera. Anda dapat bertemu dengan perwakilan klinik dan memeriksa tanggal konten terbaru di setiap halaman klinik untuk memastikan kredibilitasnya.
Blog dan tulisan pendukung kami dibuat oleh penulis profesional dengan pengalaman menulis medis setidaknya 3 tahun dan diedit oleh spesialis medis dengan keahlian klinis dan penelitian yang relevan — semua direkrut dengan hati-hati dalam tim. Kami berupaya meningkatkan akses pasien ke informasi kesehatan, menjadikannya ahli tetapi mudah dipahami. Semua tulisan mengikuti Panduan Editorial Bookimed.
Kami terdiri dari orang dan untuk orang — dan itulah nilai inti kami. Itu sebabnya semua data yang disajikan di platform dikumpulkan, diedit, ditinjau, dan diperbarui secara teratur oleh pasien kami, klinik mitra kami, dan tim kami, termasuk Dewan Penasihat Medis Bookimed, yang terdiri dari dokter terkenal secara internasional dengan keahlian bernilai lebih dari 20 tahun praktik, dan reputasi positif. Pelajari lebih lanjut tentang kami dan misi kami.
Jika Anda menemukan kesalahan atau memiliki pertanyaan tentang informasi yang disajikan di Bookimed.com, jangan ragu untuk menghubungi kami di marketing@bookimed.com.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.
Dr. Barak Rosenzweig, MD, directs the Urological Oncology Service at Sheba Medical Center. He is a uro-oncologic surgeon with nearly 20 years of experience. He treats complex urologic cancers with advanced robotic and minimally invasive methods. He is listed among Israel’s Best Doctors by Forbes.
Expertise includes tumors of the prostate, kidney, bladder, testis, and upper urinary tract. He performs robotic radical prostatectomy, kidney-sparing partial nephrectomy, and advanced laparoscopy. Diagnostics include MRI-guided fusion biopsy and imaging-based personalized planning.
He completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a Senior Physician in the Department of Urology and a Clinical Senior Lecturer at Tel Aviv University. He is a graduate of the Sheba Talpiot program. He is an active researcher with over 200 publications in urologic oncology.
Ahli terkemuka dalam teknologi NanoKnife dengan fokus pada keganasan toraks dan profil genomik inovatif di Sourasky Medical Center.
Top-rated NanoKnife specialists in Israel include Dr. Ilan Gielchinsky and Prof. Jack Baniel. These experts lead focal therapy at Hadassah and Sourasky Medical Centers. They specialize in irreversible electroporation for prostate and pancreatic cancers. Most hold certifications from the Israeli Board of Urology.
Bookimed Expert Insight: Data shows a strong trend of international training among Israel's top ablative surgeons. Dr. Almog Ben-Yaacov completed specialized NanoKnife training in London. Prof. Jack Baniel holds a consultation for $600 at Sourasky Medical Center. This global expertise helps them treat the most complex cases effectively.
Patient Consensus: Patients often mention how quickly they could walk after this minimally invasive procedure. They appreciate that the treatment avoids the side effects of traditional surgery. Many were surprised by the high level of personal care at Sourasky.
Hadassah Medical Center in Jerusalem was the first Israeli hospital to offer NanoKnife. They introduced this minimally invasive technology in 2018 for localized prostate cancer. The procedure uses electrical pulses to destroy cancer cells without harming critical surrounding tissues or nerves.
Bookimed Expert Insight: While Hadassah pioneered the technology, Sheba Medical Center has integrated NanoKnife into a multidisciplinary oncology framework. Dr. Almog Ben Yaacov at Sheba completed advanced NanoKnife training at King's College London. This international training helps specialists apply the technology to complex gastrointestinal and urological cases with high precision.
Patient Consensus: Patients note that the recovery is much faster compared to traditional thermal treatments. Many were relieved to find they could return to normal activities almost immediately. They often mention that the procedure felt less intensive and spared them from typical side effects.